您的当前位置:首页 > 行业数据 > 国内已上市和在研的系统性红斑狼疮适应症生物制品
图片属性
图片格式:PNG 图片大小:200KB 图片尺寸:2269*893
同报告图片
 / 4
国内已上市和在研的系统性红斑狼疮适应症生物制品_第1页
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
国内已上市和在研的系统性红斑狼疮适应症生物制品_第2页
fCAyMDIwIHwgMjAyMSB8IDIwMjIgfAp8LS0tLS0tfC0tLS0tLXwtLS0tLS18CnwgMzkuOTUgfCA0Ny4xOCB8IDQ3Ljg4IHwKCui1hOaWmeadpea6kO+8muivuuWNjuW5tOaKpe+8jOWNjuemj+ivgeWIuOeglOeptuaJgA==
国内已上市和在研的系统性红斑狼疮适应症生物制品_第3页
国内已上市和在研的系统性红斑狼疮适应症生物制品_第4页
国内已上市和在研的系统性红斑狼疮适应症生物制品_第5页
所属报告: 智翔金泰-公司研究报告-单抗和双抗药物全面开拓建立自免和感染疾病领先地位-240222(45页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠